{"id":838976,"date":"2025-04-17T17:07:44","date_gmt":"2025-04-17T21:07:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/"},"modified":"2025-04-17T17:07:44","modified_gmt":"2025-04-17T21:07:44","slug":"vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/","title":{"rendered":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC"},"content":{"rendered":"
\n

\n
\n Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025<\/em>
\n <\/strong>\n <\/p>\n

SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (\u201cSEC\u201d) on or about April 28, 2025, which will remove Vincerx\u2019s common stock from listing and registration on The Nasdaq Stock Market (\u201cNasdaq\u201d).<\/p>\n

On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock for the prior 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the \u201cDelisting Notice\u201d). Vincerx is not eligible for any compliance period and as a result, Nasdaq provided notice that it will suspend the trading of Vincerx\u2019s common stock at the opening of business on April 23, 2025 and that a Form 25 will be filed.<\/p>\n

Vincerx\u2019s board of directors determined that it would be in the best interests of its stockholders to dissolve, liquidate, and wind-up its business and affairs and distribute to stockholders any assets remaining after paying or providing for payment of its creditors. Given this, Vincerx does not intend to appeal the Nasdaq determination. Vincerx intends to voluntarily file a Form 25 to delist and deregister its common stock. Vincerx does not intend to make arrangements to list its common stock on another national securities exchange or other market.<\/p>\n

Once the Form 25 becomes effective, Vincerx intends to file a Form 15 to deregister with the SEC.<\/p>\n

Trading of Vincerx\u2019s common stock was suspended by Nasdaq inadvertently on April 16, 2025, instead of April 23, 2025, as stated in the Delisting Notice. Vincerx worked with Nasdaq to allow trading to resume at the opening of business on Monday, April 21, 2025 through April 22, 2025.<\/p>\n

\n About Vincerx Pharma, Inc.<\/strong>
\n
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company.<\/p>\n

Vincerx is based in San Mateo, California, and has a research facility in Monheim, Germany.<\/p>\n

\n Forward-Looking Information<\/strong>
\n
This press release contains forward-looking statements within the meaning of the federal securities laws including, but not limited to, statements about: Vincerx\u2019s intent to file a Form 25 and Form 15 with the SEC and the expected timing thereof; Vincerx\u2019s intent not to appeal Nasdaq\u2019s determination and not to list its common stock on another national securities exchange or other market; and expectations with respect to the resuming and suspension of trading of Vincerx\u2019s common stock on Nasdaq. Forward-looking statements involve risks and uncertainties that may cause actual results or performance to differ materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: risks involved in dissolving, liquidating, and winding down our business and affairs; potential effects of Nasdaq\u2019s trading suspension, resumption, and filings of Forms 25 and 15, on the trading price, trading volume and volatility of Vincerx\u2019s common stock; the timing or amount of distributions, if any, to Vincerx\u2019s stockholders; the availability and sufficiency of cash to complete an orderly dissolution, liquidation, and wind-down of the Company\u2019s business and affairs; stockholder approval of the wind-down; the Company\u2019s ability to out-license or otherwise monetize its assets and intellectual property and the amount of cash, if any, received from such activities; the risk that Vincerx may need to seek protection of the bankruptcy court; and the other factors discussed in Vincerx\u2019s reports, including its Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent reports filed with the SEC. All forward-looking statements are based on information available to Vincerx as of the date of this press release. Vincerx undertakes no duty or obligation to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Contact Information:<\/strong>\n <\/p>\n

Gabriela Jairala
Vincerx Pharma, Inc.
gabriela.jairala@vincerx.com<\/a><\/p>\n

Totyana Simien
Inizio Evoke Comms
totyana.simien@inizioevoke.com<\/a>\u00a0\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025 SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (\u201cSEC\u201d) on or about April 28, 2025, which will remove Vincerx\u2019s common stock from listing and registration on The Nasdaq Stock Market (\u201cNasdaq\u201d). On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock … <\/p>\n

Continue reading “Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-838976","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025 SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (\u201cSEC\u201d) on or about April 28, 2025, which will remove Vincerx\u2019s common stock from listing and registration on The Nasdaq Stock Market (\u201cNasdaq\u201d). On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock … Continue reading "Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T21:07:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC\",\"datePublished\":\"2025-04-17T21:07:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/\"},\"wordCount\":678,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/\",\"name\":\"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=\",\"datePublished\":\"2025-04-17T21:07:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/","og_locale":"en_US","og_type":"article","og_title":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk","og_description":"Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025 SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (\u201cSEC\u201d) on or about April 28, 2025, which will remove Vincerx\u2019s common stock from listing and registration on The Nasdaq Stock Market (\u201cNasdaq\u201d). On April 14, 2025, Vincerx received written notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its common stock … Continue reading \"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-17T21:07:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC","datePublished":"2025-04-17T21:07:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/"},"wordCount":678,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/","name":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=","datePublished":"2025-04-17T21:07:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyNDU4MSM2ODcyNzY4IzIyMDM1MjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-deregister-with-the-sec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq\u00a0and Deregister with the SEC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=838976"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838976\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=838976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=838976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=838976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}